Michael brings over 20 years of experience in operations, financing and advising senior executives of medical companies on strategy, operations, and capital market exposure. He most recently led the turnaround of one the largest point of care CT companies. With the previous proposed exit, Michael and his team were contracted by one of the nation’s leading oncology providers and became integral members of the team that led the completion of a complex proton system in addition to developing an innovative integrated CBCT imaging system that received FDA 510(k) clearance for use at that center.

Neal is a world-renowned Research Professor Emeritus in Radiology from the University of Michigan. He has written nearly 100 peer-reviewed articles, has been granted over 20 patents, and has extensive experience in technology commercialization.

Alan is a prolific entrepreneur and scientist with a specialty in radiation therapy systems. He has founded several companies, written numerous highly regarded publications, and most notably founded photo Electron (now Zeiss), as well as Mevion Medical Systems, and currently holds 24 patents.

Leonard A. Farber, MD is a successful executive in the field of healthcare with extensive experience in developing and growing centers and departments within the oncology sector. He is acknowledged for his ability to recognize emerging technologies and position them for success amongst complex markets in both the academic and private practice environments and for his expertise in strategizing and enhancing organizational relationships, growing hospital departments, launching startups, and bringing new and innovative technologies into clinical practice. Dr. Farber is currently Senior Medical Director and Section Chief of Radiation Oncology for Care to Care, a multi-specialty management system. He wrote the Radiation Oncology guidelines for insurance approval for Care to Care on all types of radiation delivery techniques and clinical indications that are used for insurance approvals for private carriers. He is the Senior Medical Director of Anatom-e information system where he is involved with product development and integration with AR and VR into clinical practice. Actively sought after for his knowledge and application of technology into the marketplace, Dr. Farber is a Scientific Advisory Board member of Genomic Health, Adgero Biopharmaceuticals, and the Global Pain Foundation/National Pain Foundation. He has served as Chief Medical Officer for the start-up Woodmont Pharmaceuticals, Inc, a biopharmaceutical company, where he was instrumental in implementing a multiphase clinical trial of a novel allergy immunotherapy delivery system and working closely with the FDA during the trial period.

Financial leader with proven operating experience building new business in venture and private equity environments, refining strategy, developing sales and marketing partnerships and managing resources. Successfully turned around Healthcare startup and commercialized patented SaaS platform. Skilled at negotiating, team building, product management, capital raising and managing resources. During my prior experience on Wall Street, I demonstrated a capability for idea generation for corporate and private equity clients and executed over $100 billion of public and private transactions for Healthcare, Media & Telecom and Consumer businesses. Specialties: Leadership, Management, Sales, Turnarounds, Strategy, Negotiating, Partnerships, Governance and Board Management, Scaling Businesses, Product Development, Mergers and Acquisitions, Corporate Finance, Strategic Development, Private Equity, Equity, High Yield Debt, Investment Grade Debt, Investment Banking, Fund Raising, Commercializing Technologies, Communication Skills